Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: O/S Issue

" Wait until the risk in the current litiagation is eliminated, then assume new risk - hopefully with a ton of cash to back up the proposition."

I agree...unless time is of essense in aquiring another enity. It would have to be an awfully attractive proposition to act swiftly.

Share
New Message
Please login to post a reply